RxDoctor Payments Data

Lehaz Kaker, MD

Hospitalist · New Brunswick, NJNPI 1720453384

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 64 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 14.1% — the pattern of someone who eats at a lot of different presentations. Among hospitalist clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,390in general payments, 2019–2025

Across 64 payments — averaging $21.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$195
  • Johnson & Johnson$154
  • Paratek Pharmaceuticals, Inc.$131
  • AstraZeneca$100
  • Novo Nordisk$80
  • Vifor Pharma, Inc.$68
  • plus $660 from 23 others

What the payments were for

  • Food & beverage$1,390100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,390 in reported general payments places this provider in the 90th percentile of 567 hospitalist providers in New Jersey.

See all hospitalist providers in New Jersey

Medicare billing

Part B allowed, 2024
$116,311
Medicare patients
553
Services billed
1,099

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban28$13,028
Gabapentin31$656
Ipratropium Bromide13$470
Atorvastatin Calcium37$283
Tamsulosin Hcl19$247
Bumetanide12$235
Oxycodone Hcl13$219
Ondansetron OdtOndansetron13$194
Furosemide26$191
Potassium Chloride11$183
Tramadol Hcl14$162
Levetiracetam14$157
Pantoprazole Sodium16$154
Levothyroxine Sodium15$124
Spironolactone22$116

Paid to pharmacies, not to this prescriber.

Other hospitalist in New Brunswick

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →